ResearcherJohn D. Dingell VA Medical CenterNo recent work listed
Ramesh Babu Batchu
Matched on ORCID iD 0000-0002-9861-5948; OpenAlex author ID A5091817261.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 7 (first author 6, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper
Papers 7
- Engraftment of mesothelin chimeric antigen receptor using a hybrid Sleeping Beauty/minicircle vector into NK-92MI cells for treatment of pancreatic cancer. First author DOI 10.1016/j.surg.2019.05.047↗
- Inhibition of Interleukin-10 in the tumor microenvironment can restore mesothelin chimeric antigen receptor T cell activity in pancreatic cancer in vitro. First author DOI 10.1016/j.surg.2017.10.056↗
- Pancreatic Cancer Cell Lysis by Cell-Penetrating Peptide-MAGE-A3-Induced Cytotoxic T Lymphocytes. First author DOI 10.1001/jamasurg.2016.2346↗
- Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer. First author DOI 10.1016/j.surg.2015.05.019↗
- Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways. First author DOI 10.3390/ph7010046↗
- EZH2-shRNA-mediated upregulation of p21waf1/cip1 and its transcriptional enhancers with concomitant downmodulation of mutant p53 in pancreatic ductal adenocarc… First author DOI 10.1016/j.surg.2013.06.041↗
- Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101. Last author DOI 10.1016/j.surg.2012.07.020↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Scott A. Gruber · 7 shared papers, 2012–2019
- Paper Engraftment of mesothelin chimeric antigen receptor using a hybrid Sleeping Beauty/minicircle vector into NK-92MI cells… DOI 10.1016/j.surg.2019.05.047↗
- Paper Inhibition of Interleukin-10 in the tumor microenvironment can restore mesothelin chimeric antigen receptor T cell acti… DOI 10.1016/j.surg.2017.10.056↗
- Paper Pancreatic Cancer Cell Lysis by Cell-Penetrating Peptide-MAGE-A3-Induced Cytotoxic T Lymphocytes. DOI 10.1001/jamasurg.2016.2346↗
- Aamer Mahmood Qazi · 5 shared papers, 2012–2016
- Paper Pancreatic Cancer Cell Lysis by Cell-Penetrating Peptide-MAGE-A3-Induced Cytotoxic T Lymphocytes. DOI 10.1001/jamasurg.2016.2346↗
- Paper Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer. DOI 10.1016/j.surg.2015.05.019↗
- Paper Ritonavir-Mediated Induction of Apoptosis in Pancreatic Cancer Occurs via the RB/E2F-1 and AKT Pathways. DOI 10.3390/ph7010046↗
- Philip Agop Philip · 1 shared paper, 2012
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.